Frankfurt Stock Exchange · Healthcare
Invest in SCHOTT Pharma AG & Co. KGaA stock from India
Indian and foreign residents can buy SCHOTT Pharma AG & Co. KGaA (1SXP) shares directly through Paasa.
By Paasa · Updated
SCHOTT Pharma AG & Co. KGaA at a glance
- Price
- €25.05+€0.35 (1.42%)
- Market cap
- €3.77B
- Day range
- €25.05 – €25.05
- P/E
- 27.53
- Dividend yield
- 0.72%
- Volume
- 80.00
- 1 month
- +6.60%
- 6 months
- +85.56%
- YTD
- +70.18%
- 1 year
- +19.29%
- 5 years
- -19.97%
SCHOTT Pharma AG & Co. KGaA statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €986.2M | €957.1M | €898.6M | €821.1M | €648.7M |
| Gross profit | €332.5M | €322.6M | €316.5M | €296.4M | €226.2M |
| Operating income | €175.9M | €192.6M | €192.4M | €164.4M | €127.7M |
| Net income | €146.5M | €149.7M | €151.8M | €125.4M | €100.8M |
| Earnings per share | €0.97 | €0.99 | €1.01 | €0.83 | €0.67 |
| EBITDA | €273.1M | €262.4M | €232.8M | €216.3M | €161.4M |
| Total assets | €1.6B | €1.4B | €1.2B | €1.2B | €739.9M |
| Total debt | €83.0M | €85.8M | €72.3M | €74.8M | €3.6M |
| Cash and short-term investments | €25.7M | €26.4M | €25.9M | €30.3M | €27.9M |
| Shareholders' equity | €891.8M | €790.4M | €690.4M | €707.3M | €418.0M |
| Operating cash flow | €179.9M | €225.3M | €181.7M | €182.1M | €132.2M |
| Free cash flow | €35.2M | €80.0M | €6.1M | €29.4M | €33.6M |
| Capital expenditure | −€144.8M | −€145.3M | −€175.5M | −€152.7M | −€98.6M |
Fiscal years as reported, the latest ending 30 Sep 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Bumrungrad Hospital Public | BZ7A.F | €5.00 | €3.97B |
| Fielmann | FIE.DE | €38.10 | €3.20B |
| BB Biotech | BBZA.DE | €54.50 | €3.01B |
| Carl Zeiss Meditec | AFX.DE | €31.44 | €2.75B |
| Drägerwerk AG & Co. KGaA | DRW3.DE | €124.40 | €2.33B |
| Dermapharm | DMP.DE | €39.35 | €1.95B |
| Drägerwerk AG & Co. KGaA | DRW8.DE | €94.20 | €1.77B |
| Bonesupport Holding AB (publ) | 2B4.F | €20.14 | €1.32B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in SCHOTT Pharma AG & Co. KGaA from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search 1SXP and buy
Find SCHOTT Pharma AG & Co. KGaA by name or by its ticker, 1SXP, and place your order.
Why invest in SCHOTT Pharma AG & Co. KGaA from India
What SCHOTT Pharma AG & Co. KGaA does
Globally, SCHOTT Pharma AG & Co. KGaA specializes in the development, manufacturing, and distribution of sophisticated containment and delivery systems specifically designed for injectable pharmaceuticals, catering to the needs of the pharmaceutical and biotechnology sectors. Their comprehensive product portfolio encompasses both polymer and glass options across various crucial categories, including syringes, ampoules, vials, and cartridges. SCHOTT Pharma AG & Co. KGaA operates in the Medical - Instruments & Supplies industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy SCHOTT Pharma AG & Co. KGaA stock from India?
Yes. Indian residents and NRIs can buy SCHOTT Pharma AG & Co. KGaA (1SXP) shares directly through Paasa. SCHOTT Pharma AG & Co. KGaA is listed on the Frankfurt Stock Exchange, in the Medical - Instruments & Supplies industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell SCHOTT Pharma AG & Co. KGaA shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.